Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycogen synthase kinase-3 alpha (GSK3A) is a serine/threonine protein kinase that plays critical roles in numerous cellular processes, including metabolism, cell signaling, proliferation, differentiation, and survival. It is a constitutively active enzyme regulated primarily by phosphorylation at Ser21, which inhibits its activity. GSK3A is involved in the Wnt/β-catenin signaling pathway, insulin signaling, and the mTOR/p70S6K pathway. Dysregulation of GSK3A has been implicated in diabetes mellitus, cancer, neurodegenerative diseases, and psychiatric disorders, making it an important therapeutic target.
GSK3A inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycogen Synthase Kinase-3 Alpha (GSK3A).